Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Cash received from interests, fees and commissions | 22.74%4.88B | 14.31%3.11B | 16.38%1.71B | -24.25%4.54B | -14.29%3.98B | -6.86%2.72B | 7.93%1.47B | -3.75%6B | 1.18%4.64B | 1.79%2.92B |
| Net increase in repurchase business capital | ---- | ---- | ---- | --13.04B | 178.23%10.72B | 207.43%10.92B | 512.68%5.99B | ---- | -53.21%3.85B | -53.74%3.55B |
| Net increase in funds disbursed | -72.27%610M | -97.78%20M | -80.00%60M | 253.85%2.76B | --2.2B | --900M | --300M | 11.43%780M | ---- | ---- |
| Net cash received from trading securities | 39.75%7.37B | --4.53B | ---- | --7.35B | --5.27B | ---- | 140.69%1.4B | ---- | ---- | ---- |
| Cash received relating to other operating activities | -20.85%2.1B | 59.01%1.58B | -20.52%490.1M | -6.60%2.67B | 62.60%2.65B | -15.70%992.37M | 107.10%616.63M | 131.19%2.86B | 63.03%1.63B | 39.80%1.18B |
| Cash inflows from operating activities | -25.86%19.63B | -27.54%12.05B | -74.93%2.55B | 185.76%30.37B | 140.24%26.48B | 80.94%16.63B | 162.09%10.18B | -48.63%10.63B | -44.94%11.02B | -51.56%9.19B |
| Staff behalf paid | 9.82%1.07B | 12.89%746.56M | 21.02%458.62M | 5.25%1.87B | -3.55%974.04M | -4.91%661.33M | -8.61%378.97M | 1.35%1.78B | -1.18%1.01B | -1.38%695.48M |
| All taxes paid | 109.81%860.19M | 112.29%603.46M | 234.00%316.33M | -3.69%554.07M | -34.64%409.98M | 54.85%284.26M | -58.10%94.71M | -32.62%575.31M | -34.55%627.27M | -62.52%183.57M |
| Cash paid for fees and commissions | 33.11%1.52B | 7.31%948.51M | 22.36%605.75M | 23.83%1.95B | -23.04%1.14B | 32.10%883.86M | 35.83%495.05M | 15.08%1.58B | 50.09%1.49B | 10.11%669.09M |
| Net increase in financial assets held for trading purposes | ---- | ---- | -88.67%604.22M | 193.30%14.8B | 32.47%13.72B | 45.23%13B | 45.88%5.33B | -53.52%5.05B | -43.09%10.36B | -36.58%8.95B |
| Net increase in resale business funds (operating) | ---- | ---- | ---- | ---- | ---- | ---- | --31.47M | ---- | ---- | ---- |
| Cash paid relating to other operating activities | -72.44%390.29M | -45.11%908.17M | -72.20%110.02M | 42.14%3.95B | -5.70%1.42B | 5.27%1.65B | 32.54%395.78M | 37.33%2.78B | 22.97%1.5B | 37.67%1.57B |
| Cash outflows from operating activities | -45.54%9.62B | -81.16%3.23B | -56.08%2.96B | 70.31%27.11B | -6.08%17.66B | 24.31%17.16B | 7.25%6.73B | -5.53%15.92B | -16.01%18.81B | -19.08%13.81B |
| Net cash flows from operating activities | 13.54%10.01B | 1,765.45%8.82B | -111.67%-403.1M | 161.41%3.25B | 213.28%8.82B | 88.52%-529.47M | 244.44%3.45B | -238.15%-5.29B | -228.32%-7.78B | -340.99%-4.61B |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 2,693.91%253.44M | --1.4B | ---- | 5,328.28%1.19B | --9.07M | ---- | ---- | 227.73%21.85M | ---- | ---- |
| Cash received from returns on investments | 309.94%585.26M | 1,237.71%370.41M | --152.03M | 220.43%588.05M | -13.56%142.77M | -48.32%27.69M | ---- | 13.55%183.52M | 32.34%165.17M | 250.30%53.58M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -78.65%316.38K | -98.70%316.38K | 3,368.84%37.84K | -83.10%1.99M | 1,750.29%1.48M | 55,776.03%24.28M | -99.71%1.09K | 463.50%11.78M | -78.84%80.08K | -88.52%43.45K |
| Cash inflows from investing activities | 447.23%839.01M | 3,316.30%1.78B | 13,938,518.95%152.07M | 717.88%1.78B | -7.22%153.32M | -3.09%51.97M | -100.00%1.09K | 27.45%217.15M | 28.40%165.25M | 242.12%53.62M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 49.52%121.66M | 34.95%63.36M | 12.85%18.52M | -34.79%116.05M | -31.27%81.36M | -17.13%46.95M | -67.31%16.41M | 14.71%177.98M | -8.17%118.38M | 46.80%56.66M |
| Cash paid to acquire investments | 61.03%3.88B | 66.29%3.47B | -72.61%314.87M | 1,289.86%3.87B | 1,140.35%2.41B | 8,527.82%2.09B | 4,689.56%1.15B | 57.90%278.4M | 92.88%194.2M | -59.92%24.2M |
| Cash outflows from investing activities | 60.65%4B | 65.60%3.54B | -71.41%333.39M | 773.27%3.99B | 696.65%2.49B | 2,540.35%2.13B | 1,471.19%1.17B | 37.68%456.38M | 36.14%312.58M | -18.30%80.86M |
| Net cash flows from investing activities | -35.29%-3.16B | 15.50%-1.76B | 84.45%-181.32M | -823.56%-2.21B | -1,486.11%-2.34B | -7,548.59%-2.08B | -3,723.04%-1.17B | -48.51%-239.22M | -46.03%-147.33M | 67.31%-27.23M |
| Financing cash flow | ||||||||||
| Cash from bonds issue | -5.05%32.32B | -27.02%17.43B | 4.40%11.55B | 3.60%48.68B | -6.53%34.04B | 6.08%23.88B | -11.91%11.07B | 5.45%46.99B | 1.26%36.41B | 0.36%22.51B |
| Cash from borrowing | -46.50%1.49B | -51.60%985.98M | -41.75%649.4M | 52.50%3.33B | 36.89%2.79B | 45.18%2.04B | 90.60%1.11B | -62.17%2.19B | -53.47%2.04B | -42.81%1.4B |
| Cash inflows from financing activities | -8.19%33.81B | -28.95%18.41B | 0.18%12.2B | 5.78%52.01B | -4.23%36.82B | 8.37%25.92B | -7.34%12.18B | -2.31%49.17B | -4.68%38.45B | -3.90%23.92B |
| Borrowing repayment | -14.12%31.37B | -11.58%20.85B | -5.58%12.58B | -4.84%43.41B | 7.70%36.53B | 11.74%23.58B | 16.93%13.33B | -3.25%45.61B | 0.09%33.92B | -0.16%21.1B |
| Dividend interest payment | -3.16%1.52B | 4.71%1.3B | 50.41%470.28M | 2.42%1.68B | 4.76%1.57B | 7.34%1.24B | 50.26%312.67M | -4.08%1.64B | -5.97%1.49B | -9.97%1.16B |
| Cash payments relating to other financing activities | -42.40%23.27M | 88.15%23.27M | 3.01%2.4M | -23.44%51.95M | 16.87%40.4M | -46.16%12.37M | -76.91%2.33M | 8.09%67.85M | 21.67%34.57M | -10.19%22.97M |
| Cash outflows from financing activities | -13.70%32.91B | -10.71%22.17B | -4.29%13.06B | -4.61%45.13B | 7.59%38.14B | 11.45%24.83B | 17.45%13.64B | -3.27%47.32B | -0.16%35.45B | -0.74%22.28B |
| Net cash flows from financing activities | 168.43%896.92M | -445.25%-3.76B | 41.58%-852.24M | 270.40%6.88B | -143.64%-1.31B | -33.51%1.09B | -195.16%-1.46B | 30.61%1.86B | -37.86%3B | -32.98%1.64B |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -255.61%-53.53M | -51.87%2.56M | -666.15%-11.54M | -82.46%8.28M | -114.56%-15.05M | -95.70%5.32M | 103.12%2.04M | -82.84%47.21M | -69.91%103.38M | -18.58%123.68M |
| Net increase in cash and cash equivalents | 49.25%7.69B | 317.51%3.3B | -274.47%-1.45B | 318.56%7.93B | 206.86%5.16B | 47.26%-1.52B | 187.09%830.04M | -167.59%-3.63B | -278.33%-4.82B | -165.10%-2.88B |
| Add:Begin period cash and cash equivalents | 25.05%39.59B | 25.05%39.59B | 25.05%39.59B | -10.28%31.66B | -10.28%31.66B | -10.28%31.66B | -10.28%31.66B | 17.94%35.29B | 17.94%35.29B | 17.94%35.29B |
| End period cash equivalent | 28.44%47.29B | 42.31%42.9B | 17.40%38.14B | 25.05%39.59B | 20.85%36.82B | -7.00%30.14B | -5.38%32.49B | -10.28%31.66B | -6.62%30.47B | -5.64%32.41B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.